Compounds > 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Myeloproliferative Disorders

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Myeloproliferative Disorders in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamishimoto, J1
Tago, K1
Kasahara, T1
Funakoshi-Tago, M1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Myeloproliferative Disorders

ArticleYear
Akt activation through the phosphorylation of erythropoietin receptor at tyrosine 479 is required for myeloproliferative disorder-associated JAK2 V617F mutant-induced cellular transformation.
    Cellular signalling, 2011, Volume: 23, Issue:5

    Topics: Amino Acid Substitution; Animals; bcl-X Protein; Cell Transformation, Neoplastic; Chromones; CREB-Bi

2011